Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
The Long Run with Luke Timmerman - A podcast by Timmerman Report
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
